{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T18:44:33Z","timestamp":1789411473340,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","aaojournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.ophtha.2017.03.041","type":"journal-article","created":{"date-parts":[[2017,4,19]],"date-time":"2017-04-19T17:45:22Z","timestamp":1492623922000},"page":"1196-1208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Risk of Ocular Hypertension in Adults with Noninfectious Uveitis"],"prefix":"10.1016","volume":"124","author":[{"given":"Ebenezer","family":"Daniel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4266-4150","authenticated-orcid":false,"given":"Maxwell","family":"Pistilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srishti","family":"Kothari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naira","family":"Khachatryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6346-5663","authenticated-orcid":false,"given":"R. Oktay","family":"Ka\u00e7maz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sapna S.","family":"Gangaputra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Nida","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric B.","family":"Suhler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Thorne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Stephen","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas A.","family":"Jabs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Nussenblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James T.","family":"Rosenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace A.","family":"Levy-Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirali P.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Kempen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2017.03.041_bib1","first-page":"410","article-title":"Uveitic glaucoma","volume":"Vol. 1","author":"Kulkarni","year":"2015"},{"key":"10.1016\/j.ophtha.2017.03.041_bib2","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1001\/archopht.120.6.714","article-title":"The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma","volume":"120","author":"Gordon","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.03.041_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ophtha.2006.05.075","article-title":"Predictive factors for open-angle glaucoma among patients with ocular hypertension in the European Glaucoma Prevention Study","volume":"114","author":"Miglior","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2017.03.041_bib4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ophtha.2006.08.031","article-title":"Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension","volume":"114","author":"Gordon","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2017.03.041_bib5","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.ophtha.2013.01.025","article-title":"Risk of elevated intraocular pressure and glaucoma in patients with uveitis: results of the multicenter uveitis steroid treatment trial","volume":"120","author":"Friedman","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2017.03.041_bib6","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1159\/000358691","article-title":"Fluctuations in intraocular pressure increase the trabecular meshwork extracellular matrix","volume":"33","author":"Zou","year":"2014","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.ophtha.2017.03.041_bib7","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1016\/S0161-6420(99)90530-4","article-title":"Inhaled corticosteroids, family history, and risk of glaucoma","volume":"106","author":"Mitchell","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2017.03.041_bib8","first-page":"478","article-title":"Dexamethasone-induced ocular hypertension in perfusion-cultured human eyes","volume":"36","author":"Clark","year":"1995","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2017.03.041_bib9","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1001\/archopht.1997.01100150377011","article-title":"Ultrastructural changes in the trabecular meshwork of human eyes treated with corticosteroids","volume":"115","author":"Johnson","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.03.041_bib10","first-page":"145","article-title":"Evaluation of the myocilin (MYOC) glaucoma gene in monkey and human steroid-induced ocular hypertension","volume":"42","author":"Fingert","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2017.03.041_bib11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ophtha.2006.07.060","article-title":"Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial","volume":"114","author":"Bengtsson","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2017.03.041_bib12","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/archophthalmol.2010.20","article-title":"Delaying treatment of ocular hypertension: the ocular hypertension treatment study","volume":"128","author":"Kass","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.03.041_bib13","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archopht.120.6.701","article-title":"The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma","volume":"120","author":"Kass","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.03.041_bib14","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3129\/can j ophthalmol.06-124","article-title":"Outcome of trabeculectomy with intraoperative mitomycin C for uveitic glaucoma","volume":"42","author":"Noble","year":"2007","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.03.041_bib15","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ajo.2007.03.013","article-title":"Long-term results of Ahmed glaucoma valve implantation for uveitic glaucoma","volume":"144","author":"Papadaki","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.03.041_bib16","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.ajo.2006.07.018","article-title":"Phacotrabeculectomy with mitomycin C in patients with uveitis","volume":"142","author":"Park","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.03.041_bib17","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0161-6420(00)00594-7","article-title":"Otago glaucoma surgery outcome study: long-term results of uveitis with secondary glaucoma drained by Molteno implants","volume":"108","author":"Molteno","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2017.03.041_bib18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/09286580701585892","article-title":"Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study","volume":"15","author":"Kempen","year":"2008","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/j.ophtha.2017.03.041_bib19","doi-asserted-by":"crossref","first-page":"b2480","DOI":"10.1136\/bmj.b2480","article-title":"Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study","volume":"339","author":"Kempen","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.ophtha.2017.03.041_bib20","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.ophtha.2015.06.041","article-title":"The risk of intraocular pressure elevation in pediatric noninfectious uveitis","volume":"122","author":"Kothari","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2017.03.041_bib21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox","year":"1972","journal-title":"J\u00a0R Stat Soc Series B Stat Methodol"},{"key":"10.1016\/j.ophtha.2017.03.041_bib22","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.survophthal.2007.06.004","article-title":"Triamcinolone acetonide in ocular therapeutics","volume":"52","author":"Jermak","year":"2007","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.03.041_bib23","doi-asserted-by":"crossref","first-page":"1916.e1","DOI":"10.1016\/j.ophtha.2005.06.009","article-title":"Outcome of intravitreal triamcinolone in uveitis","volume":"112","author":"Kok","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2017.03.041_bib24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1146\/annurev.pu.14.050193.000355","article-title":"Regression analysis for correlated data","volume":"14","author":"Liang","year":"1993","journal-title":"Annu Rev Public Health"},{"key":"10.1016\/j.ophtha.2017.03.041_bib25","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1080\/01621459.1989.10478873","article-title":"Regression analysis of multivariate incomplete failure time data by using the marginal distribution","volume":"84","author":"Wei","year":"1989","journal-title":"J\u00a0Am Stat Assoc"},{"key":"10.1016\/j.ophtha.2017.03.041_bib26","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/01.ijg.0000146391.77618.d0","article-title":"Incidence of glaucoma in patients with uveitis","volume":"13","author":"Neri","year":"2004","journal-title":"J\u00a0Glaucoma"},{"key":"10.1016\/j.ophtha.2017.03.041_bib27","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3109\/09273948.2013.824106","article-title":"Pattern of intraocular pressure fluctuation in uveitic eyes treated with corticosteroids","volume":"22","author":"Shrestha","year":"2014","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ophtha.2017.03.041_bib28","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1001\/archopht.1995.01100020100038","article-title":"Hypertension, perfusion pressure, and primary open-angle glaucoma. A population-based assessment","volume":"113","author":"Tielsch","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.03.041_bib29","first-page":"2224","article-title":"Intraocular pressure in an American community. The Beaver Dam Eye Study","volume":"33","author":"Klein","year":"1992","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2017.03.041_bib30","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0161-6420(95)31054-8","article-title":"Primary open-angle glaucoma, intraocular pressure, and systemic blood pressure in the general elderly population. The Rotterdam Study","volume":"102","author":"Dielemans","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2017.03.041_bib31","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ajo.2004.12.088","article-title":"Intraocular pressure over the clinical range of blood pressure: Blue Mountains Eye Study findings","volume":"140","author":"Mitchell","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.03.041_bib32","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/bjo.2004.048710","article-title":"Intraocular pressure and systemic blood pressure: longitudinal perspective: the Beaver Dam Eye Study","volume":"89","author":"Klein","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.03.041_bib33","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/S0161-6420(84)34142-2","article-title":"Intraocular pressure in diabetic persons","volume":"91","author":"Klein","year":"1984","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2017.03.041_bib34","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/0002-9394(67)93071-1","article-title":"Intraocular pressure in juvenile diabetics","volume":"64","author":"Traisman","year":"1967","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.03.041_bib35","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0161-6420(84)34282-8","article-title":"Association between ocular pressure and certain health parameters","volume":"91","author":"Carel","year":"1984","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2017.03.041_bib36","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/09273940701732230","article-title":"Ocular hypertension associated with ocular sarcoidosis","volume":"15","author":"Mirza","year":"2007","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ophtha.2017.03.041_bib37","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1016\/j.ophtha.2012.05.032","article-title":"Risk of hypotony in\u00a0noninfectious uveitis","volume":"119","author":"Daniel","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2017.03.041_bib38","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.ajo.2006.02.014","article-title":"LXII Edward Jackson lecture: open angle glaucoma after vitrectomy","volume":"141","author":"Chang","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.03.041_bib39","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/IAE.0b013e31818ba9ca","article-title":"Presence of crystalline lens as a protective factor for the late development of open angle glaucoma after vitrectomy","volume":"29","author":"Luk","year":"2009","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2017.03.041_bib40","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/IAE.0b013e3181ff0d5a","article-title":"Long-term trends in intraocular pressure after pars plana vitrectomy","volume":"31","author":"Lalezary","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2017.03.041_bib41","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ajo.2009.02.032","article-title":"Outcome of raised intraocular pressure in uveitic eyes with and without a corticosteroid-induced hypertensive response","volume":"148","author":"Sallam","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.03.041_bib42","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ajo.2009.10.013","article-title":"Re: Outcome of raised intraocular pressure in uveitic eyes with and without a corticosteroid-induced hypertensive response","volume":"149","author":"Nazm","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.03.041_bib43","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1136\/ard.2005.038638","article-title":"Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data","volume":"65","author":"Da Silva","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ophtha.2017.03.041_bib44","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1001\/archopht.125.11.ecs70063","article-title":"Intraocular pressure in patients with uveitis treated with fluocinolone acetonide implants","volume":"125","author":"Goldstein","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.03.041_bib45","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1001\/jamaophthalmol.2015.51","article-title":"Risk factors associated with intraocular pressure increase in patients with uveitis treated with the fluocinolone acetonide implant","volume":"133","author":"Parekh","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.03.041_bib46","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.ajo.2009.11.019","article-title":"The multicenter uveitis steroid treatment trial: rationale, design, and baseline characteristics","volume":"149","author":"Kempen","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.03.041_bib47","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/j.ophtha.2011.07.027","article-title":"Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial","volume":"118","author":"Kempen","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2017.03.041_bib48","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0002-9394(01)00830-3","article-title":"Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel","volume":"131","author":"Jabs","year":"2001","journal-title":"Am J Ophthalmol"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642016322175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642016322175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T17:27:31Z","timestamp":1719163651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642016322175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0161642016322175"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2017.03.041","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of Ocular Hypertension in Adults with Noninfectious Uveitis","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2017.03.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}